The initial diagnosis of ovarian cancer often occurs in FIGO stages III or IV due to the lack of early symptoms in localized stages, hence resulting in a relatively large tumor mass at the time of diagnosis and a consistently higher secretion of HMGB1 with subsequent depletion of sRAGE as described above. This evidence concerns the gene HMGB1 and ovarian cancer.